Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists

Bioorganic & Medicinal Chemistry Letters
Min ZhongW Mike Flanagan

Abstract

This letter describes the discovery of a novel series of tetrahydroisoquinoline (THIQ)-derived small molecules that potently inhibit both human T-cell migration and super-antigen induced T-cell activation through disruption of the binding of integrin LFA-1 to its receptor, ICAM-1. In addition to excellent in vitro potency, 6q shows good pharmacokinetic properties and its ethyl ester (6t) demonstrates good oral bioavailability in both mouse and rat. Either intravenous administration of 6q or oral administration of its ethyl ester (6t) produced a significant reduction of neutrophil migration in a thioglycollate-induced murine peritonitis model.

References

Feb 22, 2002·Medicinal Research Reviews·Helena Yusuf-MakagiansarTeruna J Siahaan
Feb 11, 2003·Acta Dermato-venereologica·Robert GniadeckiMartin Calverley
Mar 29, 2003·Expert Opinion on Biological Therapy·Jennifer Clay CatherAlan Menter
Sep 3, 2003·Nature Reviews. Drug Discovery·Motomu Shimaoka, Timothy A Springer
Feb 16, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S C KhojastehS Kenkare-Mitra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.